The predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease

Journal of Cardiology

Volumn 64, Issue 5, 2014, Pages 371-376

  Erturk, Mehmet ^a   Cakmak, Huseyin Altug ^a   Surgit, Ozgur ^a   Celik, Omer ^a   Aksu, Hale Unal ^a   Akgul, Ozgur ^a   Gurdogan, Muhammet ^b   Bulut, Umit ^a   Ozalp, Begum ^a   Akbay, Ertan ^a   Yildirim, Aydin ^a  

^a MEHMET AKIF ERSOY THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Private Kesan Hospital Department of Cardiology   (Turkey)

Author keywords

Cardiovascular mortality; Critical limb ischemia; Intermittent claudication; Neutrophil to lymphocyte ratio; Peripheral arterial occlusive disease

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CRITICAL LIMB ISCHEMIA; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; INTERMITTENT CLAUDICATION; LEUKOCYTE COUNT; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; LYMPHOCYTE; MIDDLE AGED; MORBIDITY; MORTALITY; NEUTROPHIL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK; TIME;

BIOLOGICAL MARKER;

AGED; ARTERIAL OCCLUSIVE DISEASES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MORBIDITY; NEUTROPHILS; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK; TIME FACTORS;

EID: 84912002479     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.02.019     Document Type: Article

References (32)

1. Hirsch A.T., Hiatt W.R. PAD awareness, risk, and treatment: new resources for survival-the USA PARTNERS program. Vasc Med 2001, 6:9-12. PARTNERS Steering Committee.
2. Fowkes F.G., Rudan D., Rudan I., Aboyans V., Denenberg J.O., McDermott M.M., Norman P.E., Sampson U.K., Williams L.J., Mensah G.A., Criqui M.H. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013, 382:1329-1340.
3. Gurm H.S., Bhatt D.L., Lincoff A.M., Tcheng J.E., Kereiakes D.J., Kleiman N.S., Jia G., Topol E.J. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart 2003, 89:1200-1204.
4. Kirtane A.J., Bui A., Murphy S.A., Barron H.V., Gibson C.M. Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. Am J Cardiol 2004, 93:532-536.
5. Barron H.V., Harr S.D., Radford M.J., Wang Y., Krumholz H.M. The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 2001, 38:1654-1661.
6. Kannel W.B., Anderson K., Wilson P.W. White blood cell count and cardiovascular disease. Insights from the Framingham Study. J Am Med Assoc 1992, 4(267):1253-1256.
7. Cannon C.P., McCabe C.H., Wilcox R.G., Bentley J.H., Braunwald E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators. Am J Cardiol 2001, 87:636-639. A10.
8. Pellizzon G.G., Dixon S.R., Stone G.W., Cox D.A., Mattos L., Boura J.A., Grines L.L., Addala S., O'Neill W.W., Grines C.L. Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial). Am J Cardiol 2003, 91:729-731. Stent PAMI Investigators.
9. Horne B.D., Anderson J.L., John J.M., Weaver A., Bair T.L., Jensen K.R., Renlund D.G., Muhlestein J.B. Which white blood cell subtypes predict increased cardiovascular risk?. J Am Coll Cardiol 2005, 45:1638-1643. Intermountain Heart Collaborative Study Group.
10. Ergelen M., Uyarel H., Altay S., Kul S., Ayhan E., Isik T., Kemaloglu T., Gül M., Sönmez O., Erdogan E., Turfan M. Predictive value of elevated neutrophil to lymphocyte ratio in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost 2013, (January). [epub ahead of print].
11. Gul M., Uyarel H., Ergelen M., Ugur M., Isik T., Ayhan E., Turkkan C., Aksu H.U., Akgul O., Uslu N. Predictive value of neutrophil to lymphocyte ratio in clinical outcomes of non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up. Clin Appl Thromb Hemost 2012, (November). [epub ahead of print].
12. Akpek M., Kaya M.G., Lam Y.Y., Sahin O., Elcik D., Celik T., Ergin A., Gibson C.M. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012, 110:621-627.
13. Spark J.I., Sarveswaran J., Blest N., Charalabidis P., Asthana S. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. J Vasc Surg 2010, 52:632-636.
14. Bhutta H., Agha R., Wong J., Tang T.Y., Wilson Y.G., Walsh S.R. Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg 2011, 45:227-231.
15. Rooke T.W., Hirsch A.T., Misra S., Sidawy A.N., Beckman J.A., Findeiss L.K., Golzarian J., Gornik H.L., Halperin J.L., Jaff M.R., Moneta G.L., Olin J.W., Stanley J.C., White C.J., White J.V., et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011, 58:2020-2045.
16. Reiner Z., Catapano A.L., De Backer G., Graham I., Taskinen M.R., Wiklund O., Agewall S., Alegria E., Chapman M.J., Durrington P., Erdine S., Halcox J., Hobbs R., Kjekshus J., et al. ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011, 32:1769-1818. European Association for Cardiovascular Prevention, Rehabilitation.
17. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483.
18. Brevetti G., Martone V.D., Perna S., Cacciatore F., Corrado S., Di Donato A., Di Iorio A. Intermittent claudication and risk of cardiovascular events. Angiology 1998, 49:843-848.
19. Silvestro A., Brevetti G., Schiano V., Scopacasa F., Chiariello M. Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification. Thromb Haemost 2005, 93:559-563.
20. Hoogeveen R.C., Morrison A., Boerwinkle E., Miles J.S., Rhodes C.E., Sharrett A.R., Ballantyne C.M. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study. Atherosclerosis 2005, 183:301-307.
21. ó Hartaigh B., Bosch J.A., Thomas G.N., Lord J.M., Pilz S., Loerbroks A., Kleber M.E., Grammer T.B., Fischer J.E., Boehm B.O., März W. Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Atherosclerosis 2012, 224:161-169.
22. Arbel Y., Finkelstein A., Halkin A., Birati E.Y., Revivo M., Zuzut M., Shevach A., Berliner S., Herz I., Keren G., Banai S. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis 2012, 225:456-460.
23. Gibson P.H., Croal B.L., Cuthbertson B.H., Small G.R., Ifezulike A.I., Gibson G., Jeffrey R.R., Buchan K.G., El-Shafei H., Hillis G.S. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 2007, 154:995-1002.
24. Kullar P., Weerakoddy R., Walsh S. Neutrophil-lymphocyte ratio predicts graft patency following lower limb revascularisation. Acta Chir Belg 2012, 112:365-368.
25. Tamhane U.U., Aneja S., Montgomery D., Rogers E.K., Eagle K.A., Gurm H.S. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008, 102:653-657.
26. Gary T., Belaj K., Hafner F., Hackl G., Froehlich H., Pilger E., Brodmann M. A high CHA(2)DS(2)-VASc score is associated with a high risk for critical limb ischemia in peripheral arterial occlusive disease patients. Atherosclerosis 2012, 225:517-520.
27. Azab B., Zaher M., Weiserbs K.F., Torbey E., Lacossiere K., Gaddam S., Gobunsuy R., Jadonath S., Baldari D., McCord D., Lafferty J. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010, 106:470-476.
28. Cho K.H., Jeong M.H., Ahmed K., Hachinohe D., Choi H.S., Chang S.Y., Kim M.C., Hwang S.H., Park K.H., Lee M.G., Ko J.S., Sim D.S., Yoon N.S., Yoon H.J., Hong Y.J., et al. Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2011, 107:849-856.
29. Duffy B.K., Gurm H.S., Rajagopal V., Gupta R., Ellis S.G., Bhatt D.L. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 2006, 97:993-996.
30. Núñez J., Núñez E., Bodí V., Sanchis J., Miñana G., Mainar L., Santas E., Merlos P., Rumiz E., Darmofal H., Heatta A.M., Llàcer A. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008, 101:747-752.
31. Muhammed Suliman M.A., Bahnacy Juma A.A., Ali Almadhani A.A., Pathare A.V., Alkindi S.S., Uwe Werner F. Predictive value of neutrophil to lymphocyte ratio in outcomes of patients with acute coronary syndrome. Arch Med Res 2010, 41:618-622.
32. Haumer M., Amighi J., Exner M., Mlekusch W., Sabeti S., Schlager O., Schwarzinger I., Wagner O., Minar E., Schillinger M. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. J Vasc Surg 2005, 41:610-617.